Loading…

Novanta Inc. entered a definitive agreement to acquire Riverpoint Medical from Arlington Capital Partners for $1.2 billion upfront plus a $250 million milestone payment in Q1 2027. The transaction is expected to close in Q3 2026.
“Novanta will acquire all outstanding equity interests of the parent company of Riverpoint Medical for an upfront cash consideration of $1.2 billion and a milestone payment of $250 million in the first quarter of 2027.”business.sherbrookerecord.com
Summarized from public sources; check the original articles before acting on it.